Short answer
SELECT MEDICAL HOLDINGS CORP (SEM) filed an 8-K current report with the SEC on July 1, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.01 (Completion of Acquisition or Disposition of Assets), Item 2.03 (Creation of a Direct Financial Obligation), Item 3.03 (Material Modification to Rights of Security Holders), Item 5.01 (Changes in Control of Registrant), Item 5.02 (Departure/Election of Directors or Officers), Item 5.03 (Amendments to Articles of Incorporation or Bylaws), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). $1.0 billion incremental term loan established under Select Medical’s existing credit agreement.
SELECT MEDICAL HOLDINGS CORP 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.01 · Entry into a Material Definitive Agreement
- $1.0 billion incremental term loan established under Select Medical’s existing credit agreement
- Amendment No. 12 modifies financing terms, increasing leverage and future interest obligations
- Proceeds’ purpose, interest rate and maturity require review of Exhibit 10.1
- Additional borrowing expands financial flexibility but may increase refinancing and covenant risk
Item 2.01 · Completion of Acquisition or Disposition of Assets
- Merger completed, with seven existing directors departing at closing
- Departures unrelated to disagreements, reducing governance-transition concerns
- Russell L. Carson, David S. Chernow and Robert A. Ortenzio now serve as directors
- Board composition materially reset, signaling post-merger governance under new leadership
Item 2.03 · Creation of a Direct Financial Obligation
- Section heading indicates a listing-status matter, not creation of a direct financial obligation
- Introductory Note contains the referenced disclosure investors need to assess exchange-compliance implications
Item 3.03 · Material Modification to Rights of Security Holders
- Merger completion triggered conversion of each outstanding Company Share under the merger terms
- Security-holder rights changed at the Effective Time through merger consideration mechanics
- Investors should review the merger agreement for exchange terms and treatment of excluded shares
Item 5.01 · Changes in Control of Registrant
- Merger completed, triggering a change of control at Select Medical Holdings
- Company became a wholly owned subsidiary of Parent and rollover holders
- Rollover holders retained restricted shares in the surviving company
- Transaction involved aggregate purchase price for outstanding Company shares
Item 5.03 · Amendments to Articles of Incorporation or Bylaws
- Certificate of incorporation replaced at merger closing under the Merger Agreement
- Amended and restated bylaws adopted concurrently at the merger Effective Time
- Governance documents now reflect post-merger corporate structure
- Investor impact depends on Exhibit 3.1 and 3.2 provisions affecting shareholder rights and corporate governance
Item 7.01 · Regulation FD Disclosure
- Exhibit 99.1 furnished under Regulation FD, not deemed filed under Exchange Act Section 18
- Exhibit excluded from Securities Act incorporation by reference unless specifically incorporated
- Legal-status clarification limits liability exposure, without substantive operating or financial disclosure
Item EX-99.1 · Exhibit EX-99.1
- Acquisition completed by consortium led by Robert Ortenzio, Martin Jackson, and WCAS, effective July 1, 2026
- Purchase price $16.50 per share, valuing Select Medical at approximately $3.9 billion
- Consideration represented premiums of approximately 18% and 25% to unaffected and 90-day VWAP prices
- Common stock ceasing trading; Select Medical delisting from NYSE on July 1, 2026
- Existing officers continuing, while consortium assumes operational control and majority economic interest
Other items in this filing:
- Item 5.02: Departure/Election of Directors or Officers
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other SELECT MEDICAL HOLDINGS CORP 8-K filings
Get the next SEM 8-K as it lands
Follow SEM for push alerts, or ask the research agent what this filing means.